BEIJING, Jan. 29 (Xinhua) -- After years of dedicated research, a team of Chinese scientists has unveiled critical mechanisms governing early human embryonic development, offering novel theories and ...
When you think of the “Make America Healthy Again” (MAHA) movement, you might picture fertile soil, organic farms, and homeopathic remedies. For some, that vision is a welcome change; for others, it ...
Jacobin on MSNOpinion
Silicon Valley’s latest dubious offering: designer babies
Riders of the New York City subway were startled recently by an ad campaign commissioned by a newly established reproductive ...
Introducing cell therapy--grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performance across cell therapy workflows ST. PETERSBURG, Fla., Feb. 6, 2026 ...
With a tank of zebrafish, Queensland researcher Jean Giacomotto was able to test a never-before seen genetic variant ...
Scientists, academics, and some intended parents agree that better data is needed. “We need more research. You know, we need to design better studies,” said Bryan McColgan, a writer and trained ...
Hosted on MSN
Elective IVF gains traction. Doctors have concerns.
In vitro fertilization has exploded across America. The number of babies born through assisted reproductive technologies — most of them via IVF — jumped 45% from 2013 to 2022. A more recent part of ...
Irish Examiner on MSN
'I've had cancer six times — and I'm still thriving'
Stemming from a rare genetic condition, Brian Tobin has had cancer six times since the age of 25. However, he says people can survive and thrive despite this challenge ...
Implantation bleeding is an early sign that the embryo has implanted in the uterine lining, but it can easily be mistaken for menstruation.
Early-stage venture capital in 2025-2026 totaled approximately $300 billion globally, with artificial intelligence and clean energy technologies dominating the investment landscape. While general ...
CaseBioscience® announces the launch of CaseCryo® CTG DMSO , a next-generation cryopreservation solution developed to support clinical cell therapy development, at Advanced Therapies Week (ATW) 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results